Tags

Type your tag names separated by a space and hit enter

Maple syrup urine disease. Two cases in Israel.
Isr J Med Sci. 1975 Aug; 11(8):809-16.IJ

Abstract

The first two patients in Israel in whom the diagnosis of maple syrup urine disease was confirmed are reported. The clinical course of the disease and therapeutic procedures during the first months of life are described. The age on onset and the severity of neurological symptomatology were different in the two patients. In the first, blood leucine levels were extremely high, and drastic procedures, such as peritoneal dialysis, were employed in addition to dietary treatment to lower the leucine levels to normal and to improve the patient's clinical condition. In the second infant, blood leucine levels were moderately elevated and the disease was controlled by dietary treatment alone. Neither of the patients responded to thiamine hydrochloride treatment. The two infants probably represent examples of different genotypes of the classic form of maple syrup urine disease.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

1165176

Citation

Chemke, J, and S Levin. "Maple Syrup Urine Disease. Two Cases in Israel." Israel Journal of Medical Sciences, vol. 11, no. 8, 1975, pp. 809-16.
Chemke J, Levin S. Maple syrup urine disease. Two cases in Israel. Isr J Med Sci. 1975;11(8):809-16.
Chemke, J., & Levin, S. (1975). Maple syrup urine disease. Two cases in Israel. Israel Journal of Medical Sciences, 11(8), 809-16.
Chemke J, Levin S. Maple Syrup Urine Disease. Two Cases in Israel. Isr J Med Sci. 1975;11(8):809-16. PubMed PMID: 1165176.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Maple syrup urine disease. Two cases in Israel. AU - Chemke,J, AU - Levin,S, PY - 1975/8/1/pubmed PY - 1975/8/1/medline PY - 1975/8/1/entrez SP - 809 EP - 16 JF - Israel journal of medical sciences JO - Isr J Med Sci VL - 11 IS - 8 N2 - The first two patients in Israel in whom the diagnosis of maple syrup urine disease was confirmed are reported. The clinical course of the disease and therapeutic procedures during the first months of life are described. The age on onset and the severity of neurological symptomatology were different in the two patients. In the first, blood leucine levels were extremely high, and drastic procedures, such as peritoneal dialysis, were employed in addition to dietary treatment to lower the leucine levels to normal and to improve the patient's clinical condition. In the second infant, blood leucine levels were moderately elevated and the disease was controlled by dietary treatment alone. Neither of the patients responded to thiamine hydrochloride treatment. The two infants probably represent examples of different genotypes of the classic form of maple syrup urine disease. SN - 0021-2180 UR - https://www.unboundmedicine.com/medline/citation/1165176/Maple_syrup_urine_disease__Two_cases_in_Israel_ L2 - https://www.diseaseinfosearch.org/result/4453 DB - PRIME DP - Unbound Medicine ER -